Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
In a financial emergency, knowing what to do is crucial. Discover effective steps to take to manage your situation promptly.
15,764 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
UK tax authorities plan to buy crypto forensic tools to pursue digital asset tax fraud. The move signals a broader pu...
As allogene (allo) 2025 earnings loom, investors weigh pipeline progress, collaboration milestones, and cash runway. ...
A wave of unsealed court filings shines a harsh light on ticket prices and fees. This article translates the drama in...
Micron rode a wave of AI demand to notable gains. This guide breaks down whether that momentum can persist into 2026 ...
A major adviser boosted its stake in Savara by more than a million shares during the latest quarter, wading into a bi...
Investors eye Hewlett Packard Enterprise’s 2026 earnings call for guidance on AI demand, GreenLake growth, and capita...
President Trump urged the Fed to cut rates immediately, sending ripples through cryptocurrency markets as traders pri...
This in-depth look breaks down Summit Midstream's 2025 earnings trajectory, cash-flow health, and strategic bets. Lea...
Two powerhouse energy stocks could shape the next decade. This guide explains why NextEra Energy and GE Vernova fit a...
Lumen Technologies plans to shave $1B in annual network costs by 2027, driven by AI-enabled operations and a broader ...
U.S. banks have shifted a large portion of lending to shadow lenders, sparking debate about a repeat of 2008. Analyst...